DuPont de Nemours (DD)
(Delayed Data from NYSE)
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Zacks News
5 Top S&P 500 Stocks to Bet on for Income & Growth Investors
by Priti Dhanuka
Investors seeking both growth and income in stocks can venture out to the market, at present, to make profitable investment decisions.
DuPont Inks Degasification Deal With Sun Chemical & DIC Corp
by Zacks Equity Research
The partnership supports DuPont's (DD) goal to boost access of products and technologies required to address global challenges.
Coronavirus Clouds Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemicals companies are buffeted by a downturn in demand across major markets and raw material cost pressure due to coronavirus.
DuPont's (DD) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
DuPont (DD) saw strength across food & beverage and health & wellness end markets in the second quarter.
DuPont (DD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont's (DD) adjusted earnings of 70 cents per share for Q2 beat the Zacks Consensus Estimate of 59 cents.
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Demand weakness across certain markets amid the coronavirus pandemic is likely to have impacted DuPont's (DD) sales in the second quarter.
Material ETFs Well Poised for Gains As Q2 Earnings Unfold
by Sweta Killa
The materials sector has shown remarkable performance after the reopening of the economy as industrials and business activities have picked up.
DuPont (DD) Develops GWP Product to Lower GHG Emissions
by Zacks Equity Research
DuPont (DD) aims to incorporate a decline in embodied carbon in an updated Environmental Product Declaration, with the launch of a reduced GWP Styrofoam brand insulation.
DuPont's Performance Building Solutions Launch Roof Protector
by Zacks Equity Research
DuPont (DD) Tyvek Roof Protector offers the ideal balance of protection and efficiency to get the job completed quickly, effectively and safely.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) benefits from cost synergy savings, innovation-driven investment and actions to boost cash flows.
DuPont Stock Up 64% in 3 Months: What's Behind the Rally?
by Zacks Equity Research
DuPont (DD) is benefiting from cost and productivity improvement actions, new product launches and initiatives to boost cash flows.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
DuPont (DD) gains from cost-control actions and product launches amid headwinds from soft demand and nylon pricing pressure.
International Flavors April, May Sales Dip 7% on Coronavirus Woes
by Zacks Equity Research
International Flavors' (IFF) quarter-to-date top-line numbers down on prevalent pressure in certain end-market categories across few countries due to the coronavirus pandemic.
DuPont (DD) Shares Pop 60% in 3 Months: What's Driving It?
by Zacks Equity Research
DuPont (DD) gains from cost synergy savings, new product launches and actions to drive cash flows.
International Flavors (IFF) Beats on Q1 Earnings, Scraps View
by Zacks Equity Research
International Flavors (IFF) registers sales and earnings growth in Q1 on broad-based growth in Scent and Taste segments.
DuPont's (DD) Earnings & Revenues Surpass Estimates in Q1
by Zacks Equity Research
DuPont (DD) witnessed strength across protective garments, probiotics and food & beverage businesses in Q1.
DuPont's (DD) Q1 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
DuPont's (DD) adjusted earnings of 84 cents per share for Q1 beat the Zacks Consensus Estimate of 83 cents.
DuPont Inks Europe Distribution Deal With Endure Walls
by Zacks Equity Research
DuPont (DD) envisions that the collaboration would better suit its customers in Europe.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Benefits of cost synergy savings and productivity actions are expected to get reflected on DuPont's (DD) first-quarter results.
What Lies Ahead for Materials ETFs in Q1 Earnings?
by Sweta Killa
While the major players seem to have less chances of beating earnings estimates, investors could still bet on Q1 earnings via ETFs.
DuPont (DD) Issues Preliminary Q1 Results, Suspends 2020 View
by Zacks Equity Research
DuPont (DD) expects adjusted earnings per share of 82-84 cents and net sales of $5.2 billion for first-quarter 2020.
DuPont (DD) Poised on Productivity Actions & New Products
by Zacks Equity Research
While DuPont (DD) faces headwinds from weak demand and pricing, it is gaining from productivity improvement actions and new product launches.
Coronavirus Casts a Pall Over Diversified Chemical Industry
by Anindya Barman
Soft demand and raw material cost pressure due to coronavirus pose as headwinds to diversified chemicals companies.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) gains from cost-control actions and product launches amid headwinds from soft demand and pricing pressure.
3 Must-Buy Stocks as Coronavirus Cases Spike (Revised)
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.